|
WO2021041981A1
|
|
Compositions comprising bacterial species and methods related thereto
|
|
WO2020242999A1
|
|
Pharmaceutical compositions for the treatment of hbv
|
|
TW202028190A
|
|
5-membered heteroaryl carboxamide compounds for treatment of hbv
|
|
US2020215129A1
|
|
Methods and compositions for treating gastrointestinal and inflammatory disorders
|
|
WO2020051319A1
|
|
Cyclic sulfamide compounds for treatment of hbv
|
|
WO2020051320A1
|
|
Cyclic sulfamide compounds for treatment of hbv
|
|
EP3596070A1
|
|
Process for making hepatitis b core protein modulators
|
|
CN110621672A
|
|
Cyclic sulfonamide compounds and methods of use thereof
|
|
EP3512845A1
|
|
Hepatitis b core protein modulators
|
|
TW201720820A
|
|
Hepatitis B core protein modulators
|
|
BR112016020895A2
|
|
Hepatitis B Core Allosteric Protein Modulators
|
